The pharmaceutical contract manufacturing industry has seen a flurry of merger and acquisition (M&A) activities in recent years. Several key players have been at the forefront of these transactions, shaping the landscape of this dynamic sector.

For more insights into the M&A trends in the CMO industry, download a free report sample

Here are some of the prominent companies involved in M&A within the pharmaceutical contract manufacturing industry:

1. Lonza Group:

   • Overview: Lonza is a Swiss multinational company that provides contract manufacturing services in the pharmaceutical and biotechnology sectors. The company has expanded its presence through acquisitions, aiming to offer integrated solutions to its clients.
   • Notable Acquisition: Lonza's acquisition of Capsugel, a leader in capsule technology and development, has strengthened its position in drug delivery and formulation development.

2. Thermo Fisher Scientific:

   • Overview: Thermo Fisher Scientific is a global leader in providing scientific services and products, including contract manufacturing for the pharmaceutical industry. The company has made strategic acquisitions to expand its pharmaceutical services.
   • Notable Acquisition: The acquisition of Patheon has significantly bolstered Thermo Fisher's pharmaceutical contract development and manufacturing capabilities.

3. Catalent, Inc.:

   • Overview: Catalent is a leading provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. The company has pursued a strategy of acquisition to expand its services.
   • Notable Acquisition: Catalent's acquisition of Cook Pharmica has enhanced its capabilities in biologics development and manufacturing.

4. Recipharm AB:

   • Overview: Recipharm is a Swedish pharmaceutical contract development and manufacturing organization. The company has grown through acquisitions and collaborations to extend its global footprint.
   • Notable Acquisition: Recipharm's acquisition of Consort Medical has expanded its capabilities in the development and manufacturing of inhalation and injectable drug products.

5. Aenova Group:

   • Overview: Aenova is a German pharmaceutical contract manufacturer that offers services in formulation development, manufacturing, and packaging. The company has been involved in M&A activities to broaden its portfolio.
   • Notable Acquisition: The acquisition of Haupt Pharma has strengthened Aenova's position in the pharmaceutical and nutraceutical contract manufacturing sector.

6. Piramal Pharma Solutions:

   • Overview: Piramal Pharma Solutions, a part of the Piramal Group, provides contract development and manufacturing services to the pharmaceutical and biotechnology industries. The company has expanded through acquisitions.
   • Notable Acquisition: The acquisition of Ash Stevens has added high-potency API (active pharmaceutical ingredient) capabilities to Piramal's service offerings.

7. Fareva:

   • Overview: Fareva is a French pharmaceutical contract manufacturer that specializes in manufacturing, packaging, and formulation development. The company has expanded its global presence through acquisitions.
   • Notable Acquisition: Fareva's acquisition of Avromed has furthered its capabilities in the development and manufacturing of non-sterile and liquid forms.

These key players have played a significant role in shaping the pharmaceutical contract manufacturing M&A landscape. By strategically acquiring complementary businesses and expanding their service portfolios, they aim to provide comprehensive solutions to pharmaceutical companies and meet the growing demand for contract manufacturing services in the industry.